Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Employee compensation | $ 480 | $ 931 | $ 1,006 |
| Professional fees | 88 | 485 | 322 |
| Total | 4,412 | 3,460 | 3,130 |
| IKENA ONCOLOGY INC | |||
| Employee compensation | 483 | 1,730 | 3,311 |
| Research and development expenses | 1,108 | 1,935 | 3,964 |
| Professional fees | 1,348 | 2,409 | 1,221 |
| Other | 39 | 23 | 85 |
| Total | $ 2,978 | $ 6,097 | $ 8,581 |
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable for research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|